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The maintenance of homeostatic immune sur­
veillance and the development of protective 
immune responses require that leukocytes effi­
ciently cross tissue barriers and traffic through­
out the body, moving in and out of the bone 
marrow and through lymphoid and nonlym­
phoid tissues under both normal and infected or 
inflamed conditions (von Andrian and Mackay, 
2000). The conventional multistep paradigm in 
leukocyte extravasation consists of a cascade of 
events, including tethering and rolling inter­
actions of leukocytes on the endothelial surface 
(step 1), leukocyte activation by the local chemo­
kines and/or other inflammatory signals result­
ing in the activation of integrin adhesiveness 
(step 2), and the firm adhesion of leukocytes to 
the blood vessel wall (step 3). The entire process 
is then followed by crawling and transendo­
thelial migration (TEM), by which leukocytes 
leave the blood stream and enter the site of 
inflammation (Nourshargh et al., 2010). The 
CD18 integrins (also known as 2 integrins), 
which include LFA­1 (CD11a/CD18) and Mac­1 
(CD11b/CD18), are central components of this 
process. The CD18 integrins are expressed on the 
surface of most leukocytes and play a major 
role in regulating leukocyte adhesion and re­
cruitment to damaged or infected tissues dur­
ing inflammation.
Although leukocyte recruitment is key for 
the host defense against infection and injury, 
the deregulation and/or massive infiltration of 
active leukocytes could damage the vascula­
ture and underlying tissues. Indeed, leukocyte–
 endothelial interactions and cell emigration 
are crucial events that lead to plasma leakage 
and organ dysfunction. However, studies using 
in vivo (Zeng et al., 2002) and in vitro (Huang 
et al., 1988; Burns et al., 1997) models have 
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The efficient trafficking of immune cells into peripheral nonlymphoid tissues is key to enact 
their protective functions. Despite considerable advances in our understanding of cell 
migration in secondary lymphoid organs, real-time leukocyte recruitment into inflamed 
tissues is not well characterized. The conventional multistep paradigm of leukocyte extrav-
asation depends on CD18 integrin–mediated events such as rapid arrest and crawling on 
the surface of the endothelium and transmigration through the endothelial layer. Using 
enhanced three-dimensional detection of fluorescent CD18 fusion proteins in a newly 
developed knockin mouse, we report that extravasating leukocytes (neutrophils, monocytes, 
and T cells) show delayed uropod detachment and become extremely elongated before 
complete transmigration across the endothelium. Additionally, these cells deposit CD18+ 
microparticles at the subendothelial layer before retracting the stretched uropod. Experi-
ments with knockout mice and blocking antibodies reveal that the uropod elongation and 
microparticle formation are the result of LFA-1–mediated adhesion and VLA-3–mediated 
cell migration through the vascular basement membrane. These findings suggest that 
uropod elongation is a final step in the leukocyte extravasation cascade, which may be 
important for precise regulation of leukocyte recruitment into inflamed tissues.
© 2012 Hyun et al. This article is distributed under the terms of an Attribution–
 Noncommercial–Share Alike–No Mirror Sites license for the first six months after 
the publication date (see http://www.rupress.org/terms). After six months it is 
available under a Creative Commons License (Attribution–Noncommercial–Share 
Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/
by-nc-sa/3.0/).
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(Fig. 1 A) was confirmed using Southern blot and PCR for 
WT, heterozygous (+/), and homozygous (+/+) mice 
(Fig. 1, B and C). Spleen lysates were subjected to Western 
blot analysis, and the CD18­mCFP was detected using an 
anti­GFP antibody, which cross­reacts with CFP (Fig. 1 D). 
No evidence of the proteolytic cleavage of CFP was detected 
in heterozygous and homozygous mice (Fig. 1 D). Western 
blot analysis using anti–mouse CD18 showed an increase in 
the molecular weight of CD18­mCFP corresponding to the 
size of mCFP compared with WT CD18 (Fig. 1 D). The 
total protein (confirmed by Western blot) and cell surface 
(confirmed by flow cytometry) expression levels of CD18 in 
WT and CD18­mCFP homozygous mice were similar (Fig. 1, 
D and E). In heterozygous mice, however, we generally 
detected more WT CD18 molecules than CD18­mCFP in 
Western blot analysis (Fig. 1 D), even though the total cell 
surface expression level of CD18 was identical to the expres­
sion level in WT mice. In this study, we used only CD18­
mCFP homozygous mice to corroborate our findings. The 
majority of CD18­mCFP expressed in splenocytes from ho­
mozygous mice was evenly distributed at the plasma mem­
brane (Fig. 1 F). We further confirmed that CD18 expression 
levels in neutrophils, monocytes, and T cells from CD18­
mCFP mice were similar to those in WT mice (Fig. 1 G). 
Naive CD4 T cells from WT and CD18­mCFP mice showed 
similar migration velocities, displacements, and meandering 
index on ICAM­1– and CCL21–coated surfaces (Fig. 1 H). 
We also examined whether the KI animal is more susceptible 
to infection because of abnormalities in the immune response. 
No significant defects in bacterial clearance were observed in 
the peritoneal lavage at 6 and 24 h after septic challenge with 
cecal ligation and puncture (Fig. 1 I; Rittirsch et al., 2009). 
A key prerequisite for our experiments is to verify that our 
CD18­mCFP mice exhibit the normal migratory properties 
of leukocytes in vivo. Intravital imaging of the leukocytes in 
the venules of the TNF­treated cremaster muscle revealed 
that the number of adherent leukocytes and the velocity of 
the rolling leukocytes in CD18­mCFP mice were not differ­
ent than those in WT mice (not depicted).
Uropod elongation is a common final step  
in leukocyte extravasation
Transgenic mice used in MP­IVM express fluorescence probes 
intracellularly, thus allowing the visualization of cellular posi­
tioning or cell–cell interactions; however, the fluorescence 
signal in our CD18­mCFP KI mouse was predominantly 
localized at the cell membrane (Fig. 1 F). With this mouse, 
we performed optimal scanning of leukocyte morphology 
to detect novel cellular structures during cell migration. Live 
MP­IVM images showed that leukocyte adhesion increased 
significantly in the blood vessels in response to CXCL2 super­
fusion (Phillipson et al., 2006), and a large number of CD18+ 
cells actively emigrated from the cremaster venules (Fig. 2 A 
and Video 1). Strikingly, MP­IVM revealed that the majority 
of extravasating leukocytes were extremely elongated during 
transmigration (Fig. 2 B and Video 1). The elongated leukocytes 
suggested that little change occurs in vessel and endothe­
lial cell barrier function during the transmigration of leu­
kocytes. These studies suggest the presence of mechanisms that 
uncouple leukocyte transmigration from endothelial barrier 
function for macromolecular transport (He, 2010). Endothe­
lial cells form a transmigratory cup, which is a membrane 
projection enriched with ICAM­1 and VCAM­1 that sur­
rounds adherent leukocytes on the apical side of the endothe­
lium (Carman and Springer, 2004). Emigrating leukocytes are 
then encapsulated in endothelial domes to minimize increases 
in vascular permeability (Phillipson et al., 2008). During 
the procedure, leukocyte LFA­1 and endothelial ICAM­1 
remain bound and are redistributed together to form a distinct 
ring­like structure, which is maintained until TEM is complete 
(Shaw et al., 2004). After TEM and before approaching the 
interstitial area, leukocytes must detach their tails from the 
basolateral side of the endothelial layer and/or basement 
membrane. Thus, leukocyte tail detachment is considered to 
be a final step in the completion of leukocyte extravasation, 
although it is not clear how this event occurs.
The functions of the CD18 integrins have been studied 
using monoclonal antibodies and small­molecule inhibitors 
that block integrin­mediated adhesion as well as gene­deficient 
mice that do not express integrins or their ligands. Given the 
importance of the dynamic regulation of integrin activation 
during leukocyte migration, simple loss­of­function approaches 
are not sufficient to gain an understanding of integrin biology 
in vivo. Despite recent advances in studies concerning leuko­
cyte migration and trafficking in lymphoid and nonlymphoid 
tissues, the visualization of endogenous cell surface molecules 
on intact tissues has been challenging (Bonasio et al., 2007; 
Friedman et al., 2010). In this study, we generated a knockin 
(KI) mouse in which CD18 is fused with monomeric CFP 
(mCFP). With enhanced three­dimensional detection and 
extended in vivo z­series sections using multiphoton intra­
vital microscopy (MP­IVM), we report that extravasating leu­
kocytes (neutrophils, monocytes, and effector T cells) at the 
tissue site show delayed uropod detachment and become 
extremely elongated before the completion of transmigra­
tion across the endothelium. Surprisingly, these cells deposit 
CD18+ microparticles at the subendothelial layer while re­
tracting the stretched uropod.
RESULTS
Generation of KI mice in which CD18 is fused with mCFP
Live cell imaging of fluorescent cell membrane fusion pro­
teins, including a recent approach to visualize LFA­1 on the 
surface of live T cells using a genetically encoded tag that 
binds to quantum dot (Bonasio et al., 2007), has been limited 
to in vitro assays and mostly transparent organisms in vivo. 
To visualize the real­time subcellular distribution of endoge­
nous CD18 during leukocyte migration in intact tissues, we 
generated a KI mouse in which CD18 is fused with mCFP 
(Fig. 1 A). CD18­mCFP mice are fertile and exhibit no obvious 
phenotypical or functional abnormalities. The correct integra­
tion of the mutant CD18 gene into the mouse germline 
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leukocyte classes. Neutrophils were visualized in WT mice 
through the i.v. injection of low doses of the Alexa Fluor 488–
anti­Gr1 antibody (Chiang et al., 2007). We also conducted 
in vivo imaging in lysozyme M (LysM)–GFP mice, in which 
neutrophils and monocytes were labeled with GFP (Faust 
et al., 2000), and in CX3CR1­GFP mice, which express GFP 
in monocytes, natural killer cells, and some T cells (Jung et al., 
2000). Finally, the morphology of extravasating effector CD4 
T cells was analyzed after the adoptive transfer of the CFSE­
 labeled cells into WT recipient mice. After the venules were 
stimulated with chemokines or fMLP, we found that uropod 
elongation in all leukocyte subsets was similar to that observed 
in CD18­mCFP mice (Fig. 3, A and B; and Videos 2–5). 
reached >30 µm in length, which is at least fourfold longer 
than the size of the rolling and crawling leukocytes in the 
blood vessel. Additionally, >50% of the total leukocytes spent 
>20 min before detaching the uropod from the subendothe­
lium and proceeding into the interstitium in response to 
CXCL2, fMLP, and TNF (Fig. 2, A–E; and Video 1). A lin­
ear regression analysis showed a significant positive correlation 
of the maximum cell length with the extravascular retention 
time, suggesting that leukocyte extravasation becomes delayed 
because of tail elongation (Fig. 2 F).
CD18 is expressed on all leukocyte subsets; therefore, we 
closely examined uropod elongation during cell extravasation 
on individual cell types using mouse strains with differentiated 
Figure 1. Generation of CD18-mCFP KI 
mice. (A) Gene targeting procedure for CD18-
mCFP KI mice. The mCFP sequence was 
knocked into the C terminus of the mouse 
integrin CD18 subunit. (B and C) Southern 
blot (B) and PCR (C) analyses were performed 
using genomic DNA isolated from the tails of 
WT, CD18-mCFP heterozygous (+/), and 
homozygous (+/+) mice. (D) Western blot 
analyses for both CFP and CD18 were per-
formed using spleen lysates from WT, hetero-
zygous, and homozygous mice. For the 
Western blot analysis of CD18 integrin, WT 
mice and two homozygous mice with differ-
ent ages (4 and 14 wk old) were used. A rep-
resentative image is shown from experiments 
repeated three times. (E) The cell surface ex-
pression of CD18 was measured on neutro-
phils isolated from WT, heterozygous, and 
homozygous mice (blue; red, isotype control) 
by flow cytometry. A representative dataset is 
shown from experiments repeated three 
times. (F) The CD18-mCFP expression in sple-
nocytes isolated from homozygous mice was 
visualized. Bars, 20 µm. (G) Granulocytes 
(Gr1+), macrophages (F4/80), monocytes 
(CD115), and T cells (CD3) were isolated from 
WT and CD18-mCFP mice, labeled with anti-
CD18 antibody, and analyzed by flow cytom-
etry to compare the cell surface expression of 
CD18. MFI, mean fluorescence intensity.  
(H) In vitro migration of naive CD4 T cells 
isolated from CD18-mCFP and WT mice was 
performed on ICAM-1– and CCL21-coated 
surfaces at 37°C. The cell migration velocity 
(Vel; µm/min), displacement rate (Ds; µm/min), 
and meandering index (Mi; µm/µm) shown in 
the figure were not significantly different.  
A dataset represents data from experiments 
repeated three times. (I) The local bacterial burden 
of WT and CD18-mCFP mice was evaluated  
at 6 and 24 h in the peritoneal lavage after 
sepsis challenge by cecal ligation and puncture. 
(G and I) Representative datasets are shown 
from experiments repeated three times. The 
results are expressed as the mean ± SEM.
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endothelium is largely mediated through interactions be­
tween the CD18 integrins (LFA­1 and Mac­1) and ICAM­1 
(Sarantos et al., 2008; Bartholomäus et al., 2009; Sumagin et al., 
2010). This bond at the leukocyte uropod must be released 
once TEM is complete, allowing the migration of the leuko­
cytes into the interstitium. Fluorescence microscopy of ex­
travasating leukocytes revealed that CD18 was localized at the 
leukocyte uropod (Fig. 4 C). Although the uropodal distribu­
tion of CD18­mCFP signals during leukocyte extravasation 
indicated a possible role for CD18 in the interaction between 
the uropod of extravasating leukocytes and the basolateral 
membrane of the endothelial cell layer, it was unclear whether 
a direct relationship existed between CD18 and uropod elon­
gation. To explore this potential relationship, we i.v. injected 
LFA­1 and Mac­1 blocking antibodies that readily diffuse into 
the subendothelial layer (Fig. 4 D), where they could inhibit 
specific CD18 integrins that mediate stable and prolonged tail 
retention during uropod elongation. The i.v. injection of a 
Mac­1 (CD11b) blocking antibody resulted in the rapid de­
tachment of intravascular adherent cells during CXCL2 stim­
ulation, whereas the cell length and elongation time were not 
affected in the extravascular area (Fig. 4, E and F; and Video 7). 
The i.v. injection of an LFA­1 (CD11a) blocking antibody 
also resulted in the clearance of adherent intravascular cells, 
To further evaluate leukocyte elongation in the endothelia 
of different tissues during infection, we next investigated 
the extravasation of LysM­GFP cells in Candida albicans– 
or Leishmania major–infected mouse ears. Similar to the cells 
in the cremaster venules, extravasating LysM­GFP cells in the 
infected ear venules also exhibited extreme uropod elongation 
(Fig. 3 C and Video 6). Therefore, our data suggest that uropod 
elongation is a common final step of leukocyte extravasation.
Elongation is mediated by LFA-1 at the tail  
of extravasating leukocytes
To analyze the ultrastructure of leukocyte tail elongation, 
we first performed scanning electron microscopy (EM). We 
found that the elongated leukocytes were located at the peri­
vascular area, whereas the tip of the uropod remained tethered 
within the basement membrane (Fig. 4 A). Transmission EM 
further revealed that the tip of the uropod was not located 
inside the lumen of the vessel or on the apical side of the endo­
thelial cells; instead, the tip was always attached to the baso­
lateral side of the endothelial cell layer (Fig. 4 B). These data 
suggest that uropod elongation results from the strong inter­
action between the tail of the extravasating leukocytes and 
the basolateral membrane of the endothelial cell layer. The 
strong adhesive interaction between the leukocytes and the 
Figure 2. Uropod elongation during leu-
kocyte extravasation of CD18-mCFP mice. 
(A) CD18-mCFP mice were used to visualize 
leukocytes in cremaster venules using MP-IVM. 
The rolling leukocytes were visualized in the 
unstimulated cremaster muscle venules (left). 
The venules were stimulated with chemo-
kine (1 nM CXCL2), and the adhered/extrava-
sating leukocytes are shown (right). Texas red 
dextran was i.v. injected to stain the blood 
vessel (red). A representative still image is 
shown from at least 10 stimulated venule 
images from the cremasters of five mice. See 
corresponding Video 1. (B) Representative 
time-lapse images of cell elongation during 
leukocyte extravasation were taken from the 
videos of CXCL2-stimulated venules in CD18-
mCFP mice. The arrows indicate the elonga-
tion direction. Bars, 30 µm. (C–E) Cell lengths 
in each step of transmigration, rolling,  
crawling, and extravascular (Ext.) retention. 
The extravascular retention times were also 
measured in CXCL2 (C)-, fMLP (D)-, and TNF  
(E)-stimulated cremaster venules of CD18-
mCFP mice. The cell lengths were determined 
from the longest distance across cells (from 
head to tail) at each stage. The extravascular 
retention times represent the time period 
between the end of TEM and the completion 
of tail detachment from the endothelium. The 
cell length and the extravascular retention 
time were measured from images of at least three venules stimulated for >30 min. Horizontal lines indicate the mean. *, P < 0.005. (F) Correlation between 
the elongation and the extravascular retention time during leukocyte extravasation. The cell length and the extravascular retention time were measured from 
images of at least three venules stimulated for >30 min with CXCL2. P = 0.003.
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detached from the endothelium more quickly than WT cells 
(Fig. 4, G and H; and Video 9). Importantly, blocking LFA­1 
and Mac­1 did not significantly affect the cell migration ve­
locity in the tissue interstitium (Fig. 4 I).
VLA-3 mediates penetration through  
the basement membrane
The process of leukocyte migration involves at least three 
interdependent events: attachment at the leading edge, cell con­
traction, and detachment at the trailing edge. Therefore, leukocyte 
but, in contrast to the Mac­1 blocking antibody, the uro­
pod length of extravascular leukocytes was significantly 
decreased, and the majority of leukocytes detached their 
uropods quickly from the endothelium, spending <10 min 
in attachment compared with the control IgG–injected 
mice (Fig. 4, E and F; and Video 8). To further evaluate the 
specific role of LFA­1 in the uropod elongation, we used 
CD11a KO mice. Although few CD11a­deficient leukocytes 
were adhered after CXCL2 stimulation, those cells that could 
complete TEM showed no significant uropod elongation and 
Figure 3. Uropod elongation is a common final step in all leukocyte subsets during extravasation. (A) The cremaster venules in Alexa Fluor 
488–anti-Gr1 antibody–injected (i.v.) WT, LysM-GFP, and CX3CR1-GFP mice were stimulated with chemokines (1 nM CXCL2 or CCL2) and 1 µM fMLP. 
The representative images of the cell elongation (top) and the cell lengths in each extravasation step (rolling, crawling, and extravascular [Ext.] reten-
tion; bottom) are shown. The cell lengths of each extravasating step were measured from at least five stimulated cremaster venules from three mice 
per stimulatory condition. Horizontal lines indicate the mean. *, P < 0.005. See corresponding Videos 2–4. (B) CFSE-labeled effector CD4 T cells were 
adoptively transferred to the WT recipient mice. The cremaster from the recipient mouse was stimulated with CXCL12 and IP10 and imaged using  
MP-IVM. The representative images of adhesion, interstitial migration, and elongation of the CD4 T cells are shown in the stimulated cremaster venules of 
the recipient mice. Cell morphology at each extravasating step was investigated from at least five stimulated cremaster venules from three mice. See 
corresponding Video 5. (C) MP-IVM was performed on the ear venules of LysM-GFP mice after PBS inoculation (Basal) or infection with C. albicans or 
L. major. A representative still image is shown among at least three basal and infected mice ear venule images for each condition. See corresponding 
Video 6. (A–C) The boxed areas indicate elongated leukocytes. Bars, 30 µm.
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layer (Fig. 5, A and D; and Video 10). This result suggests the 
presence of an additional force at the head that can facili­
tate the penetration of the cells at the leading edge through the 
basement membrane and their migration into the interstitium.
Although the mechanisms by which leukocytes penetrate 
the vascular basement membrane are unclear, a blocking anti­
body against VLA­6 (61) has been shown to inhibit neutro­
phil crawling along the subendothelial basement membranes 
(Dangerfield et al., 2002, 2005). However, the involvement 
of VLA­6 integrin in neutrophil migration is cytokine 
specific and mediates IL­1–dependent neutrophil migra­
tion in cremaster venules but does not support neutrophil 
migration in response to TNF or fMLP. Therefore, in this 
study we focused on another major laminin­binding inte­
grin in neutrophils, VLA­3 (31; CD49c/CD29), which 
migration can be conceptualized as a cyclic process, where the 
balance between adhesion at the front and de­adhesion at the 
rear is important for the regulation of directional cell migration. 
The velocity profile of extravasating leukocytes showed syn­
chronous movements of the head and tail from intravascular 
adhesion until completion of TEM (Fig. 5 A and Video 10), sug­
gesting proper balance between adhesion and de­adhesion at 
the front and rear of migrating cells, respectively. During elon­
gation, however, the speed of the tail was decreased and ap­
proached zero as the result of strong LFA­1/ligand binding at the 
uropod (Fig. 5 A and Video 10). Interestingly, the dramatic incon­
sistency between the tail and head speeds during cell elongation 
was not only caused by the decreased tail speed, but also by a 
two­ to threefold increase in the head speed in the near perpen­
dicular direction (angles between 45° and 90°) to the endothelial 
Figure 4. Leukocyte elongation is mediated by LFA-1 
at the tail. (A) A scanning EM image of an extravasating 
leukocyte from the endothelium of a CXCL2-stimulated 
cremaster from a CD18-mCFP mouse is shown. A represen-
tative image is shown from two independent scanning EM 
experiments. (B) Two representative transmission EM images 
are shown together with corresponding cartoons that indi-
cate endothelial cells (EC) in red and neutrophils in gray. 
Among 50 randomly selected neutrophil images from two 
independent experiments that showed perivascular elonga-
tion, 100% of these cells laid the uropod attached to the 
basolateral side of the endothelial cell layer but not its apical 
side. Transmission EM was independently performed two 
times using the CXCL2-stimulated cremasters of CD18-mCFP 
mice. Interst., interstitium; Lu., lumen. (C) CFP signal in an 
elongated CD18-mCFP is shown in rainbow colors. Texas red 
dextran was i.v. injected to indicate the blood vessel (red), 
the cremaster muscle of CD18-mCFP mice was stimulated 
with CXCL2, and then the tissue was fixed. The arrow indi-
cates that CD18 is localized at the leukocyte uropod. Three-
dimensional images of CFP and Texas red were taken using 
MP-IVM, and the images were processed as extended images 
using the Volocity software. Bars: (A and B) 1 µm; (C) 10 µm. 
(D) Antibody diffusion into the perivascular space through  
i.v. injection. Mice were immunized in one ear with 5 µg 
Keyhole Limpet Hemocyanin emulsified in complete Freund’s 
adjuvant. 4 d later, 50 µg PE-conjugated anti–mouse CD11a 
antibody (M17/4) or CD11b antibody (M1/70) was i.v. injected. 
After 30 min, the mice were sacrificed, and the leukocytes 
were extracted from the ear by collagenase digestion of the 
tissue. In vivo labeling of intradermal leukocytes was then 
evaluated by flow cytometry. The plot represents the 
CD45+CD4+ lymphocytes from anti-CD11a– or anti-CD11b–
treated mice (black lines; gray closed histograms indicate 
PBS-treated mice). (E–H) The cell lengths (E) and extravascu-
lar retention times (F) of CD18-mCFP cells were measured in 
the CXCL2-stimulated cremaster venules of CD18-mCFP 
mice in the presence of the IgG isotype control or CD11a (M17/4) or CD11b (M1/70) blocking antibodies. The cell lengths (G) and extravascular retention 
times (H) of the granulocytes labeled with Alexa Fluor 488–anti-Gr1 antibody were measured in WT and CD11a KO mice. The cells were visualized using 
MP-IVM. The leukocytes located in the interstitium and the intravascular area have been excluded from our analysis. The cell length and the extravascular 
retention time were measured from images of at least three venules stimulated for >30 min in the cremasters of two CXCL2-stimulated mice. *, P < 0.05; 
**, P < 0.0001. See corresponding Videos 7–9. (I) The interstitial migration velocities of CD18-mCFP cells were analyzed in CXCL2-stimulated cremaster 
tissues from CD18-mCFP mice in the presence of IgG isotype control or CD11a or CD11b blocking antibody using MP-IVM. The velocities were measured 
from cremaster tissues of two CXCL2-stimulated mice per condition. (E, G, and I) Horizontal lines indicate the mean.
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the head speed as well as the subsequent elongation of 
extravasating leukocytes, thus increasing the extravascular 
retention time (Fig. 5, B, E, G, and H; and Video 11). Im­
portantly, blocking VLA­3 did not decrease cell migration 
velocity in the tissue interstitium (not depicted; Lämmer­
mann et al., 2008). Compared with control, the VLA­3–cKO 
neutrophils dramatically inhibited cell elongation and in­
creased the perivascular retention time (Fig. 5, C, F, G, and H; 
and Video 12). In addition, the VLA­3–cKO neutrophils 
gained access to the interstitial space using random directions 
of egress along the entire length of the vessel (Fig. 5 F). 
Therefore, our data suggest that the uropod elongation during 
leukocyte extravasation is mediated by a retention force at the 
contact between the leukocyte uropod and the basolateral 
has been implicated in chemotactic migration on the base­
ment membrane proteins in response to IL8 and fMLP 
(Yauch et al., 1998; Elphick et al., 2009). In addition to neu­
trophils, mouse CD4 T cells and monocytes also express high 
levels of VLA­3 on the cell surface (unpublished data). To 
assess the function of VLA­3 in leukocyte elongation, the 
VLA­3 blocking peptide LXY2 was used (Yao et al., 2009). 
To further determine the precise contributions of VLA­3 
during neutrophil extravasation, we generated a conditional 
KO of VLA­3 (VLA­3–cKO) by crossing 3­flox mice with 
those expressing Cre under the granulocyte­specific elastase­2 
promoter (Ela­Cre). Deletion of the floxed 3 subunit allele and 
absence of the protein were confirmed (not depicted). Block­
ing VLA­3 with LXY2 completely abolished the increase in 
Figure 5. Leukocyte elongation is main-
tained by VLA-3 integrin–mediated pen-
etration through the endothelial basement 
membrane at the leading edge. (A–C) The 
extravasating LysM-GFP cells or Alexa Fluor 
488–anti-Gr1 antibody–stained granulocytes 
were tracked after stimulation with CXCL2 in 
mice treated with the control (A) or VLA-3 
blocking peptide (B) and in VLA-3–cKO mice 
(C). The cell lengths (top) were measured at 
each time point during migration. The veloci-
ties of the head and tail (bottom) of migrating 
cells were measured by tracking the positions 
of the leading edge and uropod at each time 
point with Volocity software and plotted at 
the indicated time points. A representative 
dataset of the cell length and velocity profiles 
was paired among three independent analyses 
of each condition. See corresponding Videos 
10–12. (D–F) The correlations between the 
angle from the venule and the cell length 
during extravasation are shown for control 
(D), VLA-3 blocking peptide–treated (E), and 
VLA-3–cKO (F) mice. The cell lengths and the 
angles from each mouse were analyzed using 
MP-IVM. The maximum angle of the venule 
and the longest length of each cell were mea-
sured during granulocyte extravasation in 
MP-IVM. The angles and the cell lengths of 
extravasating cells were measured from at 
least five stimulated cremaster venules of 
three mice. (G) Cell lengths were measured at 
each time point during extravascular reten-
tion in control, VLA-3 blocking peptide–
treated, and VLA-3–cKO mice from videos 
taken with MP-IVM. The data are additional 
representatives of cell length profiles in  
A–C. (H) Extravascular retention times were 
measured in the control peptide treated–,  
Ela-Cre, VLA-3 blocking peptide–treated, and 
VLA-3–cKO mice from videos taken with  
MP-IVM. Extravasating LysM-GFP cells in the 
cremaster venules of LysM-GFP mice were 
tracked for the control and VLA-3 blocking peptide treatments. The LXY2 peptide was superfused onto the exteriorized cremaster muscle for VLA-3 
integrin blocking. For the analysis of Ela-Cre and VLA-3–cKO mice, Alexa Fluor 488–anti-Gr1 antibody was i.v. injected to visualize the granulocytes. 
The extravascular retention time was measured from at least five stimulated cremaster venules from three mice per condition.
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membrane of the endothelium, and an additional force at the 
head, induced by integrins like VLA­3, which interact with 
components in basement membrane.
Leukocytes deposit microparticles at the endothelium
Consistent with our findings, others also have reported 
uropod elongation during leukocyte extravasation (Mempel 
et al., 2003; Peters et al., 2008). However, extreme uropod 
elongation and prolonged leukocyte extravasation are coun­
terintuitive, as these features might delay the overall immune 
surveillance and initiation of leukocyte effector functions. 
We therefore explored the biological consequences of the 
uropod elongation. Tail elongation and the release of a large 
fraction of integrin­enriched microparticles from the elon­
gated tail through the damaged cell membrane have been de­
scribed as a mechanism for uropod detachment during the 
migration of numerous cell types, including fibroblasts (Regen 
and Horwitz, 1992; Fuhr et al., 1998; Palecek et al., 1998; 
Richter et al., 2000; Kirfel et al., 2004; Rigort et al., 2004), 
cancer cells, T cells, and primary chondrocytes (Zimmermann 
et al., 2001). MP­IVM analysis of the cremaster venules 
of CD18­mCFP mice revealed that small microparticles 
(<1 µm) often remained in the perivascular area, whereas the 
extravasating leukocytes retracted their tails. These micro­
particles exhibited CFP intensity, suggesting the presence of 
CD18 integrins in the particles (Fig. 6 A and Video 13). The 
generation of microparticles during extravasation was also 
confirmed using in vivo imaging of LysM­GFP mice (Fig. 6 A 
and Video 14) and in vitro imaging of human T cells and 
neutrophils transmigrating through TNF­stimulated human 
Figure 6. Extravasating leukocytes deposit CD18-enriched micro-
particles at the subendothelial layer during the stretched uropod 
retraction. (A) Microparticle formation from the uropods of elongated 
leukocytes was visualized in the CXCL2-stimulated venules of CD18-mCFP 
(top) and LysM-GFP mice (bottom). The circles indicate extravasating 
leukocytes. A series of representative time-lapse images are shown among 
at least five microparticle formation videos from the MP-IVM analysis of 
the cremaster venules from CD18-mCFP and LysM-GFP mice. See corre-
sponding Videos 13 and 14. (B) Microparticles were generated from human 
neutrophils during the in vitro transmigration through a TNF-stimulated 
HUVEC monolayer. The circle indicates a transmigrating neutrophil 
through the HUVEC monolayer. A series of representative time-lapse  
images are shown among three independent microparticle formation  
videos of in vitro migration. See corresponding Video 15. (A and B) Arrows 
indicate microparticles. (C) Microparticles formed during the transmigra-
tion of primary human T cells and neutrophils toward 0.2 µg chemokines 
(CXCL12 for T cells and CXCL2 for neutrophils) through a TNF-stimulated 
HUVEC layer grown on basement membrane (BM)–coated transwells 
(dashed lines; middle and right). After incubation at 37°C for 1 h, the cells 
were labeled with anti-CD18 antibodies (CBR LFA1/2 and TS1/18) and Alexa 
Fluor 488–anti–mouse IgG antibody after fixation. Three-dimensional  
images were taken using multiphoton microscopy. Representative still images 
are shown among three microparticle formation videos of the in vitro  
transwell chemotaxis of human T cells and neutrophils. A schematic  
description of the assay is shown (left). See corresponding Video 16.  
(D) Microparticles (MP) derived from transmigrating human T cells and 
neutrophils were counted. Cell numbers were counted from three indepen-
dent experiments described in C. The results are expressed as the mean ± 
SEM. (E) Microparticle formation from the uropods of the elongated gran-
ulocytes was visualized in the CXCL2-stimulated venules of VLA-3–cKO 
mouse by i.v. injection of Alexa Fluor 488–anti-Gr1 antibody. The circle 
indicates an extravasating leukocyte. The arrow shows the formation of a 
microparticle. A series of representative time-lapse images are shown from 
three microparticle formation videos from the MP-IVM analysis of the 
cremaster venules of VLA-3–cKO mice. See corresponding Video 17.  
(F) Scanning EM was performed to detect submicrometer-sized LFA-1–
expressing microparticles. Microparticles were isolated from CXCL2-stimu-
lated cremaster tissue by collagenase digestion and centrifuge as described 
in Materials and methods. Magnetic beads conjugated with anti–rat IgG 
were used to collect CD11a antibody (M17/4)–bound particles from the 
lower molecular weight fraction than normal cells. Scanning EM of  
magnetic beads bound to LFA-1–positive particles revealed that there are  
a large number of LFA-1–expressing microparticles, whose sizes are in 
submicrometer ranges. Bars: (A and E) 30 µm; (B and C) 10 µm; (F) 1 µm.
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transgenic mice only provide information regarding cell 
shape, tissue distribution, or cell–cell interactions. The goals 
of this study were to investigate the detailed cellular structure 
of actively migrating leukocytes at local inflamed tissues and 
provide knowledge of how leukocytes regulate integrins 
during the transition from one step to the next in the multistep 
extravasation cascade. Using newly generated CD18­mCFP KI 
mice, we have uncovered a final common step in leukocyte 
extravasation in which the uropods of transmigrating cells 
remain bound to the endothelium for an extended period of 
elongation before retracting their tails and migrating into 
the interstitial tissue space. Second, our experiments have 
revealed that these cells deposit CD18+ microparticles at the 
subendothelial layer during extravasation.
LFA­1 and Mac­1 were suggested to have redundant 
roles during leukocyte migration because in vitro studies re­
ported that both integrins could bind the same ligand (Rothlein 
et al., 1986; Springer, 1990; Diamond et al., 1991). However, 
recent intravital imaging studies have shown that LFA­1 and 
Mac­1 act through distinct mechanisms during leukocyte ad­
hesion and crawling (Phillipson et al., 2006; Shulman et al., 
2009). It was suggested that adhesion to the endothelium 
is mediated by LFA­1, whereas intravascular crawling is me­
diated by Mac­1 in neutrophils (Phillipson et al., 2006). In 
monocytes and lymphocytes, however, crawling was shown 
to be LFA­1 dependent (Auffray et al., 2007; Shulman et al., 
2009). This result indicates the possibility that transmigration 
through the endothelium might be distinctly regulated by 
LFA­1 and/or Mac­1 in different leukocyte subsets and at 
different extravasation steps. Our data suggest that the strong 
interaction between the uropod of leukocytes and the baso­
lateral side of the endothelium during cell elongation is primar­
ily mediated by LFA­1 but not by Mac­1. Consistent with 
these results, we also observed similar uropod elongation dur­
ing the in vivo extravasation of effector T cells, which express 
low levels of Mac­1.
Although there is ample evidence that many leukocyte 
subsets can generate microparticles and secrete them into the 
extracellular space (Dalli et al., 2008; Pluskota et al., 2008; 
Shefler et al., 2010), the function of the leukocyte­derived 
microparticles is less clear. One of the most important fea­
tures of microparticles is that they contain cytosolic compo­
nents of their original cells and expose the extracellular side 
of the membrane from which they form to the outer surface. 
Thus, these miniature versions of cells might be an important 
channel for remote intercellular communications between 
leukocytes and endothelial cells and other cells within the 
body. However, it is currently unknown whether all extra­
vasating leukocytes or only a subpopulation of cells are able 
to generate microparticles because the detection of micro­
particles (<0.5 µm) has been impeded in our study by the 
resolution limit of MP­IVM. Alternatively, several mecha­
nisms have been proposed for LFA­1 detachment at the tail 
during leukocyte migration. In T cells, a contractile force 
generated by nonmuscle myosin type IIA (MyH9) is critical for 
detaching inactivated LFA­1 from ICAM­1 and retracting the 
umbilical vein endothelial cells (HUVECs; Fig. 6, B and C; 
and Videos 15 and 16). The numbers of microparticles formed 
from human T cells and neutrophils were not significantly 
different in our in vitro TEM assay (Fig. 6 D). The micro­
particles were also readily detected in VLA­3–cKO mice 
(Fig. 6 E and Video 17), suggesting that the adhesion medi­
ated by LFA­1, but not VLA­3, is more critical for microparticle 
formation. Indeed, microparticle formation was not observed in 
CD11a KO mice with MP­IVM (Fig. 4, G and H; and Video 9). 
To further investigate the presence of leukocyte­derived 
CD18+ microparticles in the endothelium, we performed 
scanning EM. After stimulating the mouse cremaster venules 
with chemokines, the intravascular contents were washed 
and the venules were digested. The low­molecular­weight 
fraction, including the submicrometer range of microparti­
cles, was collected using high­speed centrifugation, which 
has been shown to produce a pure preparation of microparti­
cles (Distler et al., 2005; Scanu et al., 2008; Shefler et al., 
2010). The microparticles were subsequently purified using 
anti–LFA­1 antibody–coated beads. The ultrastructural analy­
sis of the CD18+ microparticles isolated from stimulated 
tissues showed multiple spherical particles ranging from 100 
to 500 nm in diameter (Fig. 6 F). The contractile force at the 
tail of extravasating leukocytes is important for the retraction 
of the trailing edge and for squeezing and propelling the cell 
body through pores in the basement membrane and pericytes 
(Lämmermann et al., 2008). Members of the nonmuscle myosin 
II family mediate cellular contraction, and these proteins are 
controlled by myosin light chain kinase (MLCK) and Rho­
associated protein kinases (ROCKs; Morin et al., 2008; 
Nourshargh et al., 2010). Pretreating cells with blebbistatin 
or Y27632 (Soriano et al., 2011) resulted in the extreme 
elongation of tails and the dramatic decrease in transmigra­
tion of human T cells and neutrophils through the HUVEC 
monolayer and the number of microparticles remaining at 
the basolateral side of HUVECs (unpublished data).
DISCUSSION
Among the established techniques to study leukocyte traf­
ficking in vivo, the direct observation of leukocyte rolling 
and migration using MP­IVM is one of the most important 
experimental approaches. Indeed, recent studies of leukocyte 
trafficking using MP­IVM have provided novel and impor­
tant insights into the physiological and pathological migration 
patterns of leukocytes and their role in health and disease. 
This information has been essential for the development of 
new antiinflammatory therapies to treat chronic inflamma­
tion and autoimmune disease (Lebwohl et al., 2003; Stüve 
and Bennett, 2007). One of the most common methods for 
studying distinct leukocyte subsets using MP­IVM involves 
the isolation and in vitro fluorescent labeling of cells from 
donor mice followed by their reintroduction into a recipient; 
however, this approach subjects cells to a large amount of 
ex vivo handling. Transgenic mice expressing fluorescence 
proteins in a cell type–specific fashion are alternatives to 
ex vivo–purified and fluorescently labeled cells. However, 
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adhesion (Video 17). Thus, we concluded that the base­
ment membrane proteins are not directly involved in the 
formation of microparticles. Although we cannot completely 
rule out the possibility that leukocytes interact with ICAM­
1–expressing pericytes, our transmission EM data showed that 
pericytes were rarely present at the site of leukocyte elonga­
tion and microparticle formation.
The endothelial lining of the vasculature forms a physical 
barrier between the blood and the underlying tissues. There­
fore, one can assume that disruptions at the endothelial junc­
tions and/or openings in the vascular walls during leukocyte 
extravasation might cause leakage of fluid and large molecules 
into the tissues. The direct effect of inflammatory mediators 
on endothelial cell damage and the contribution of leukocyte 
extravasation to microvessel permeability are thus easily con­
founded (He, 2010). However, emerging evidence has shown 
that cooperative interactions between the endothelium and 
leukocytes sustain vascular homeostasis during leukocyte 
TEM under normal immune surveillance and inflammation 
(Nottebaum et al., 2008; Rowe and Weiss, 2008). The delayed 
dissociation of the uropods from the subendothelial layer 
during extravasation might be necessary to provide enough 
time to reseal the endothelium after TEM; thus, vascular pro­
tection could be provided through the generation of CD18+ 
microparticles from the tip of the uropod. Microparticles 
likely deposit leukocyte cell membrane on the endothelial 
cell surface. Therefore, it is tempting to speculate that CD18+ 
microparticles could function as a membrane seal or repre­
sent a special type of paracrine signaling machinery involved 
in endothelial communications to secure cell–cell junctions. 
Alternatively, this seal might also act as a guiding structure for 
trailing or neighboring leukocytes to modulate both the 
speed and route of their chemotaxis.
MATERIALS AND METHODS
Mice. CD18­mCFP KI mice were generated at the Gene Targeting and 
Transgenic Core facility at the University of Rochester and backcrossed 
to C57BL/6 for six generations. For gene targeting, the genomic DNA 
was isolated from a bacterial artificial chromosome clone containing the 
mouse integrin CD18 subunit gene. The pBluescript­based target vector, 
which includes a loxP flanked neor cassette, was used. The mCFP gene 
was fused to the last exon (exon 16) of the CD18 gene with a 6­aa linker 
(GGPVAT; Kim et al., 2003). The 5 region of homology, containing 
exon 16 and the diphtheria toxin (DTA)–negative selection gene, and 
the 3 region of homology were subcloned into the up­ and downstream 
regions of the loxP flanked neor cassette, respectively. The neor cassette 
was excised using Cre recombinase. For the generation of granulocyte­
specific VLA­3 KO mice, Ela­Cre KI mice were purchased from The 
European Mouse Mutant Archive, in which Cre­recombinase is ex­
pressed in the myeloid cells in place of the Ela gene, permitting condi­
tional mutagenesis in the myeloid precursors of target genes tagged with 
loxP sites (Tkalcevic et al., 2000). Ela­Cre mice were crossed with 3­Flox 
(gift from A. Sonnenberg, The Netherlands Cancer Institute, Amster­
dam, Netherlands) mice for four to five generations to achieve the dele­
tion of the 3 gene in the transgenic mice. The mice were genotyped 
using PCR and DNA isolated from tail tissues. For Ela­Cre, the primers 
F (5­CATGACACCCCCACTGTCGTGTCC­3), R (5­TGGCAC­
CACAGAAATGACCTCCAC­3), and Lx (5­TTTGGTGCACGGT­
CAGCAGATTGG­3) were used to generate bands of 615 bp and 185 bp for 
uropod (Morin et al., 2008). Evans et al. (2006) has shown in 
neutrophils and monocytes, but not in lymphocytes, that 
shedding of an active heterodimeric fragment of LFA­1 plays 
a role in cell detachment after TEM in cantharidin blister 
fluid. It was also shown that MMP­9 cleaves between Ala705 
and Ile706 in the CD18 integrins (Vaisar et al., 2009). Thus, it 
is tempting to speculate that the modulation of LFA­1 deac­
tivation and the detachment from its ligands might control 
microparticle formation and the extravascular retention time 
of extravasating leukocytes.
Once leukocytes pass the endothelium, they face an­
other mechanical barrier, the venular basement membrane. 
It has recently been shown that the venular basement mem­
brane contains preformed regions that express low levels of 
certain basement membrane components (Wang et al., 2006; 
Nourshargh et al., 2010). The mechanisms by which leukocytes 
penetrate the vascular basement membrane structure remain 
unclear, but depending on the vascular bed and the leukocyte 
subtype, these mechanisms could involve leukocyte receptors 
for basement membrane proteins (e.g., integrins) and leuko­
cyte proteases (e.g., neutrophil elastases and MMPs). Indeed, 
the genetic ablation of VLA­3 and selective inhibition of the 
VLA­3–laminin interaction significantly decreased neutrophil 
penetration through the basement membrane and substantially 
increased the extravascular retention time (Fig. 5). Major ligands 
for VLA­3 in the basement membrane include laminin­8 
(4:1:1) and laminin­10 (5:1:1). Recruitment of leu­
kocytes was dramatically reduced in laminin­8–deficient mice 
(Kenne et al., 2010). In addition, the Kd value of VLA­3 for 
binding to laminin­10 was estimated to be around 1 nM in 
the presence of Mn2+ (Nishiuchi et al., 2003). Therefore, this 
strongly suggests that, together with VLA­6 (Dangerfield et al., 
2002, 2005), VLA­3 may play an important role in guiding 
leukocytes through the venular basement membrane. VLA­3 
is expressed in many human leukocyte subsets as well, includ­
ing neutrophils (Yauch et al., 1998), monocytes (Ammon et al., 
2000), and T cells (Wayner et al., 1993; Sato et al., 1999), 
with relatively different expression levels. Although compre­
hensive studies that compare different T cell and monocyte 
subpopulations or other immune cell types have not been per­
formed, it remains a possibility that these cells use common 
integrins like VLA­3 during extravasation or the same leuko­
cyte type can use different integrins depending on the local 
tissue milieus (Dangerfield et al., 2002, 2005).
Previous studies have shown that the LFA­1 interaction 
with high density ICAM­1 induces leukocyte polarization 
and migration (Allingham et al., 2007; Dixit et al., 2011; 
Shulman et al., 2012). Although it is not known whether 
intracellular signals cross talk between LFA­1 and VLA­3, 
activated LFA­1 might simultaneously localize at the lead­
ing edge along with VLA­3 during early cell adhesion, and 
the leukocytes might differentially segregate these inte­
grins during extravasation. Nonetheless, in our study, we 
observed that the majority of the uropod elongations and 
microparticle formations were mediated through the LFA­1 
and ICAM­1 interactions independent of VLA­3–mediated 
JEM Vol. 209, No. 7 
Article
1359
acquired at a resolution of 256 × 256 pixels, with a pixel dwell time of 2 µs, 
using step sizes of 1 µm to a depth of 25–30 µm every 30 s. CFP, GFP/CFSE, 
and Texas red were visualized using band­pass filters with 460/80­nm, 
519/25­nm, and 607/26­nm bandwidths, respectively. For imaging the cre­
master and ear venules, the mice were initially anesthetized through an in­
traperitoneal injection of pentobarbital sodium at a dose of 65 mg/kg, and 
the hair on the skin of the imaging area was removed. For imaging the 
cremaster blood vessels, the right cremaster muscle was exteriorized and 
covered with warmed physiological solution (containing the following 
components: 131.9 mM NaCl, 4.7 mM KCl, 2.0 mM CaCl2, 1.2 mM 
MgSO4, and 18 mM NaHCO3, pH 7.4) at 37°C and equilibrated with gas 
containing 0% O2, 5% CO2, and 95% N2 to maintain tissue PO2 <15 torr 
(Kim and Sarelius, 2004). The mice were subsequently placed on a custom­
designed platform, and anesthesia was maintained with isoflurane for 
restraint and to avoid psychological stress and pain on the animal during 
imaging. The core body temperature of the mice was maintained using a 
warming pad set to 37°C, and Texas red dextran (70,000 molecular weight; 
Invitrogen) was i.v. injected (20 mg/kg) via femoral vein to label the blood 
vessels immediately before imaging. To image granulocytes in WT, CD11a 
KO, Ela­Cre, or VLA­3–cKO mice, 0.12 mg/kg Alexa Fluor 488–anti­Gr1 
antibody was i.v. injected during experiments. The blood vessels were stim­
ulated by superfusion of chemokines (1 nM CXCL2 or CCL2) or the bacte­
rial chemoattractant (1 µM fMLP). For TNF stimulation, TNF (0.5 µg in 
250 µl saline) was intrascrotally injected 4 h before in vivo imaging. To in­
vestigate the effect of CD18 integrin inhibition on leukocyte extravasation, 
100 µg CD11a (M17/4) or CD11b (M1/70) blocking antibody was i.v. in­
jected in the presence of CXCL2. To investigate the role for VLA­3 integrin 
on leukocyte extravasation, 100 nM VLA­3 blocking peptide was super­
fused, or VLA­3–cKO was used. For imaging the infected ears, C. albicans 
(from M. Wellington, University of Rochester Medical Center, Rochester, 
NY) or L. major in 10 µl PBS buffer (105 cells/ear) was intradermally injected 
into LysM­GFP mice 6 h before in vivo imaging. The anesthetized mice 
were laid in a lateral recumbent position on a custom­designed platform to 
expose the ventral side of the ear pinna for imaging. For observations of 
extravasating leukocytes, venules with diameter range 20–60 µm were chosen. 
For interstitial migration of leukocytes, the interstitium was randomly 
selected 20 µm outside vessels. Volocity software was used to track the mor­
phological changes and movements of the leukocytes.
EM. Leukocyte extravasation was first observed in the CXCL2­stimulated cre­
master venules of CD18­mCFP mice using MP­IVM. The cremaster was im­
mediately dissected from the body after euthanization and fixed with 2.5% 
glutaraldehyde. The tissue was further processed for scanning and transmission 
EM in the Electron Microscope Research Core at the University of Rochester.
HUVEC-grown transwell migration of human T cells and neutro-
phils. HUVECs were grown on basement membrane protein–coated tran­
swells and stimulated with TNF. T cells and neutrophils were prepared from 
human PBMCs. In brief, HUVECs were grown to confluency in transwells 
coated with the basement membrane extract (Corning) overnight before be­
ing placed on Matrigel (BD) prepared with 0.2 µg chemokines (CXCL12 for 
T cells; CXCL2 for neutrophils) in a 24­well plate. After the HUVECs were 
stimulated with TNF (0.1 µg per transwell insert) at 37°C for 4 h, 105 T cells 
or neutrophils were placed in the transwell and incubated at 37°C for 1 h. 
The cells were fixed, and then the transwell was carefully separated. Multi­
photon or confocal microscopy was used to obtain three­dimensional images 
of the transwell for detection of leukocytes and microparticles.
Microparticle characterization with scanning EM. The cremaster mus­
cles of C57BL/6 mice were superfused with saline solution containing 
CXCL12 at 37°C for 2 h. After euthanasia, the blood was immediately 
washed out with 10 ml PBS buffer, and then the cremaster muscle was 
minced. The minced tissue was treated with 3 ml of 0.5% Collagenase II 
(Invitrogen) in HBSS containing 3 mM CaCl2 at 37°C for 1 h. The supernatant 
was collected after high­speed centrifugation and then labeled with anti–mouse 
WT and mutant, respectively. For the integrin 3 primers, P1 (5­GAACA­
ACATCTGCCTGGAGT­3) and P2 (5­GTATGACTTCTGCCAT­
GTAGC­3) were used to generate bands of 442 bp and 494 bp for WT 
and flox, respectively. The removal of the gene by Cre­mediated recom­
bination was confirmed using primers P1 and P3 (5­CAACAGCACT­
GCTGTAGCA­3) to produce a 427­bp band (Margadant et al., 2009). 
For all experiments and further breeding, the transgenic mice with a 
brown coat color (coat color of Ela­Cre parents) were selected. VLA­3 
expression in VLA­3–cKO, Ela­Cre, and WT mice was detected with poly­
clonal anti–mouse VLA­3 antibody (AF2787; R&D Systems). C57BL/6, 
LysM­GFP (Faust et al., 2000), CX3CR1­GFP (Jung et al., 2000), and 
CD11a KO (Ding et al., 1999) were maintained in a specific pathogen–
free environment at the University of Rochester’s animal facility. The 
Institutional Review Board of the University of Rochester approved all 
animal experiments.
Mouse neutrophil, T cell, and monocyte preparation. Mouse neutro­
phils were isolated from bone marrow (Hamada et al., 2009). In brief, femurs 
and tibias were harvested and stripped of all muscle and sinew. Bone marrow 
then was flushed out with 10 ml RPMI medium containing 5% FBS on ice. 
Cells were pelleted by centrifuging for 3 min at 1,500 rpm, and then eryth­
rocytes were depleted. After being resuspended at 5 × 107 cells/ml in HBSS, 
cells were layered on a Percoll gradient (3 ml of 55%, top; 3 ml of 65%, mid­
dle; 4 ml of 80% Percoll) and centrifuged at 2,000 rpm for 30 min at 10°C. 
Mature neutrophils were finally recovered at the interface of the 65 and 80% 
fractions. Monocytes were gated with anti­CD115 antibody from bone mar­
row cells. Naive mouse CD4 T cells were isolated from whole spleen and 
lymph node suspensions by negative selection using the complement method, 
purity >80% by flow cytometry. Effector OT­II CD4 T cells were gener­
ated through the in vitro activation of naive T cells using the OVA323–339 
peptide and irradiated T­depleted splenocytes in the presence of 10 U/ml 
IL­2, 20 ng/ml IL­12, and 40 mg/ml anti–IL­4 (clone 11B11). After 5 days 
of priming, the effector cells were purified with Ficoll and labeled with 
CFSE (Invitrogen).
In vitro T cell migration. Delta T dishes (Thermo Fisher Scientific) were 
coated overnight at 4°C with 20 µg/ml Protein A and 4 µg/ml mouse 
CCL21 (R&D Systems), washed, and then incubated with 10 µg/ml mouse 
ICAM­1 (R&D Systems) at room temperature for 2 h. Naive mouse CD4 
T cells were placed on the dish. Image acquisition was conducted on a 
microscope (TE2000­U microscope; Nikon) using 20× objectives coupled 
to a CoolSNAP HQ charge­coupled device (Roper Scientific). Migration 
analysis was performed using Volocity software (PerkinElmer).
Adoptive transfer of effector T cells. Effector OT­II CD4 T cells, of 
which preparation was described in Mouse neutrophil, T cell, and monocyte 
preparation, were transferred into the recipient mouse immediately before 
imaging, and the recipient mouse cremaster was superfused with 12.5 nM 
CXCL12 and 10 nM IP10 (PeproTech) for MP­IVM.
LysM-GFP bone marrow chimeric mice generation. Bone marrow 
was isolated from both LysM­GFP and C57BL/6 mice. To generate mice 
with a reduced frequency of LysM­GFP–positive cells, lethally irradiated 
WT recipients (C57BL/6) received 5 × 106 bone marrow cells/mouse, 
where 20% and 80% of the cells were derived from LysM­GFP and WT 
donor mice, respectively. GFP­expressing cells from the peripheral blood 
were used to confirm the engraftment. 8–12 wk after irradiation, the mice 
were used for MP­IVM.
MP-IVM of blood vessels in mouse cremaster and ear venules. To 
visualize leukocyte motility during extravasation, MP­IVM was performed 
using an FV1000­AOM multiphoton system (Olympus) equipped with a 
25× NA1.05 water immersion objective. For two­photon excitation, a Mai­
Tai HP Ti:Sa Deep See laser system (Spectra­Physics) was tuned to 820 nm 
for CFP/Texas red and 900 nm for GFP/Texas red. The images were 
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